BCL2 and B-cell non-Hodgkin lymphoma: For example, it has been demonstrated in models of B-cell lymphoma that BET inhibition modulates the expression of pro- and anti-apoptotic BCL-2 family members to induce apoptosis through intrinsic mitochondrial apoptotic pathways [305,306].